article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.

BioTech 144
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). This year we saw the maturation of Claims and Health Information Exchanges, which enable a cost-effective and straightforward process for researchers to gain access to identified patients’ data.

Health IT 110
article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. Some of the key subsectors within digital health include: Telehealth: This includes companies that provide remote patient monitoring, virtual doctor visits, and other services.